Omicron: A SARS-CoV-2 variant of real concern

被引：20

作者：

Gattinger, Pia ^{[1
]}

Tulaeva, Inna ^{[1
,2
]}

Borochova, Kristina ^{[1
]}

Kratzer, Bernhard ^{[3
]}

Trapin, Doris ^{[3
]}

Kropfmuller, Anna ^{[4
]}

Pickl, Winfried F. ^{[3
,5
]}

Valenta, Rudolf ^{[1
,5
,6
]}

机构：

[1] Med Univ Vienna, Div Immunopathol, Dept Pathophysiol & Allergy Res, Ctr Pathophysiol Infectiol & Immunol, Vienna, Austria

[2] Sechenov First Moscow State Med Univ, Dept Clin Immunol & Allergy, Lab Immunopathol, Moscow, Russia

[3] Med Univ Vienna, Inst Immunol, Ctr Pathophysiol Infectiol & Immunol, Vienna, Austria

[4] Klinikum Peterhof, Osterreich Gesundheitskasse, Baden, Switzerland

[5] Karl Landsteiner Univ Hlth Sci, Krems, Austria

[6] NRC Inst Immunol FMBA Russia, Moscow, Russia

来源：

ALLERGY | 2022年 / 77卷 / 05期

关键词：

COVID-19; Omicron; protective antibodies; SARS-CoV-2; vaccine; variants of concern;

D O I：

10.1111/all.15264

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：1616 / 1620

页数：5

共 9 条

[1] Receptor binding domain-IgG levels correlate with protection in residents facing SARS-CoV-2 B.1.1.7 outbreaks
Blain, Hubert
Tuaillon, Edouard
Gamon, Lucie
Pisoni, Amandine
Miot, Stephanie
Delpui, Valentin
Si-Mohamed, Nejm
Niel, Clemence
Rolland, Yves
Montes, Brigitte
Groc, Soraya
Rafasse, Sophia
Dupuy, Anne-Marie
Gros, Nathalie
Muriaux, Delphine
Picot, Marie-Christine
Bousquet, Jean
[J]. ALLERGY, 2022, 77 (06) : 1885 - 1894
[2] Neutralization of SARS-CoV-2 requires antibodies against conformational receptor-binding domain epitopes
Gattinger, Pia
Niespodziana, Katarzyna
Stiasny, Karin
Sahanic, Sabina
Tulaeva, Inna
Borochova, Kristina
Dorofeeva, Yulia
Schlederer, Thomas
Sonnweber, Thomas
Hofer, Gerhard
Kiss, Renata
Kratzer, Bernhard
Trapin, Doris
Tauber, Peter A.
Rottal, Arno
Kormoczi, Ulrike
Feichter, Melanie
Weber, Milena
Focke-Tejkl, Margarete
Loffler-Ragg, Judith
Muhl, Bernhard
Kropfmuller, Anna
Keller, Walter
Stolz, Frank
Henning, Rainer
Tancevski, Ivan
Puchhammer-Stockl, Elisabeth
Pickl, Winfried F.
Valenta, Rudolf
[J]. ALLERGY, 2022, 77 (01) : 230 - 242
[3] Antibodies in serum of convalescent patients following mild COVID-19 do not always prevent virus-receptor binding
Gattinger, Pia
Borochova, Kristina
Dorofeeva, Yulia
Henning, Rainer
Kiss, Renata
Kratzer, Bernhard
Muehl, Bernhard
Perkmann, Thomas
Trapin, Doris
Trella, Martina
Ettel, Paul
Tulaeva, Inna
Pickl, Winfried F.
Valenta, Rudolf
[J]. ALLERGY, 2021, 76 (03) : 878 - 883
[4] In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies
Li, Dapeng
Edwards, Robert J.
Manne, Kartik
Martinez, David R.
Schafer, Alexandra
Alam, S. Munir
Wiehe, Kevin
Lu, Xiaozhi
Parks, Robert
Sutherland, Laura L.
Oguin, Thomas H., III
McDanal, Charlene
Perez, Lautaro G.
Mansouri, Katayoun
Gobeil, Sophie M. C.
Janowska, Katarzyna
Stalls, Victoria
Kopp, Megan
Cai, Fangping
Lee, Esther
Foulger, Andrew
Hernandez, Giovanna E.
Sanzone, Aja
Tilahun, Kedamawit
Jiang, Chuancang
Tse, Longping, V
Bock, Kevin W.
Minai, Mahnaz
Nagata, Bianca M.
Cronin, Kenneth
Gee-Lai, Victoria
Deyton, Margaret
Barr, Maggie
Von Holle, Tarra
Macintyre, Andrew N.
Stover, Erica
Feldman, Jared
Hauser, Blake M.
Caradonna, Timothy M.
Scobey, Trevor D.
Rountree, Wes
Wang, Yunfei
Moody, M. Anthony
Cain, Derek W.
DeMarco, C. Todd
Denny, Thomas N.
Woods, Christopher W.
Petzold, Elizabeth W.
Schmidt, Aaron G.
Teng, I-Ting
[J]. CELL, 2021, 184 (16) : 4203 - +
[5] Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies
Planas, Delphine
Bruel, Timothee
Grzelak, Ludivine
Guivel-Benhassine, Florence
Staropoli, Isabelle
Porrot, Francoise
Planchais, Cyril
Buchrieser, Julian
Rajah, Maaran Michael
Bishop, Elodie
Albert, Melanie
Donati, Flora
Prot, Matthieu
Behillil, Sylvie
Enouf, Vincent
Maquart, Marianne
Smati-Lafarge, Mounira
Varon, Emmanuelle
Schortgen, Frederique
Yahyaoui, Layla
Gonzalez, Maria
De Seze, Jerome
Pere, Helene
Veyer, David
Seve, Aymeric
Simon-Loriere, Etienne
Fafi-Kremer, Samira
Stefic, Karl
Mouquet, Hugo
Hocqueloux, Laurent
van der Werf, Sylvie
Prazuck, Thierry
Schwartz, Olivier
[J]. NATURE MEDICINE, 2021, 27 (05) : 917 - +
[6] SARS-CoV-2 Omicron Variant Neutralization in Serum from Vaccinated and Convalescent Persons
Roessler, Annika
Riepler, Lydia
Bante, David
von Laer, Dorothee
Kimpel, Janine
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (07) : 698 - +
[7] Antibodies elicited by SARS-CoV-2 infection or mRNA vaccines have reduced neutralizing activity against Beta and Omicron pseudoviruses
Sievers, Benjamin L.
Chakraborty, Saborni
Xue, Yong
Gelbart, Terri
Gonzalez, Joseph C.
Cassidy, Arianna G.
Golan, Yarden
Prahl, Mary
Gaw, Stephanie L.
Arunachalam, Prabhu S.
Blish, Catherine A.
Boyd, Scott D.
Davis, Mark M.
Jagannathan, Prasanna
Nadeau, Kari C.
Pulendran, Bali
Singh, Upinder
Scheuermann, Richard H.
Frieman, Matthew B.
Vashee, Sanjay
Wang, Taia T.
Tan, Gene S.
[J]. SCIENCE TRANSLATIONAL MEDICINE, 2022, 14 (634)
[8] Molecular definition of severe acute respiratory syndrome coronavirus 2 receptor-binding domain mutations: Receptor affinity versus neutralization of receptor interaction
Vogel, Monique
Augusto, Gilles
Chang, Xinyue
Liu, Xuelan
Speiser, Daniel
Mohsen, Mona O.
Bachmann, Martin F.
[J]. ALLERGY, 2022, 77 (01) : 143 - 149
[9] Sequence analysis of the emerging SARS-CoV-2 variant Omicron in South Africa
Wang, Lulan
Cheng, Genhong
[J]. JOURNAL OF MEDICAL VIROLOGY, 2022, 94 (04) : 1728 - 1733

← 1 →